Vitrification of oocytes

The vitrification of oocytes allows women to preserve their fertility and postpone pregnancy to a later date.

What is vitrification?

When is it recommended?

As a fertility preservation method, oocyte vitrification is recommended on the same basis as any other fertility preservation treatment:

  • Women who wish to have children at a later date
  • Women who have been diagnosed with cancer or other conditions which require gonadotoxic treatments
  • Women who have had repeated ovarian surgery (for example in the case of endometriosis)
  • Patients for whom we recommend carrying out embryo transfer in a later cycle: This may be recommended if there is a risk of OHSS, development of polyps, hydrosalpinx or hydrometra, absence of sperm, etc.
  • Patients who have a poor response or previously failed treatment: If pre-implantation genetic diagnosis is recommended, a sufficient quantity of oocytes will need to be obtained and vitrified.

In 30 years, the IVI Group has helped more than 200,000 dreams come true.


97% of our patients said they would recommend IVI. We work with you at every stage of the treatment, providing support and care.


IVI has a worldwide reputation for innovative research and has developed and patented pioneering techniques and technologies.


IVI is one of the largest fertility providers in the world, with over 65 clinics in 9 countries.




Oocyte vitrification for cancer patients

Oocyte vitrification for cancer patients

Request your first appointment

Back to toparrow_drop_up